Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

Correction to prior msg- 2nd quote from ICER Final Report reads:

Finally, the majority of the Council judged belimumab to provide a “high” long-term value for money and voclosporin to provide an “intermediate” long-term value for money, at current pricing.
(p. 10-11 of 166 pgs.)

Now, just where are those seasick pills?

It's past time for ICER to drop any pretense about being concerned about the health of Lupus Nephritis patients.

This twisted report clearly shows they're in the tank for GSK and the insurance payers.

*Note that GSK has representation within ICER (Aurinia does not) and that GSK also "donates" money to ICER (Aurinia does not).

It's up to the expert doctors and the patients to right this ship.